Molecular analysis of HLA class I (HLA-A and -B) and HLA class II (HLA-DRB1) genes in Japanese patients with multiple sclerosis (Western type and Asian type). 1998

T Ono, and M R Zambenedetti, and K Yamasaki, and Y Kawano, and N Kamikawaji, and H Ito, and M Sakurai, and Y Nishimura, and J Kira, and I Kanazawa, and T Sasazuki
Department of Genetics, Medical Institute of Bioregulation, Kyushu University, Fukuoka, Japan.

The types of HLA-A, -B and -DRB1 genes were studied in 146 Japanese patients with multiple sclerosis (MS) using polymerase chain reaction-sequence-specific oligonucleotide probe analysis. Fifty-seven patients who displayed selective clinical involvement of the optic nerve and spinal cord were classified as having Asian type MS. The other 89 patients had disseminated central nervous system involvement and were classified as having Western type MS. The frequency of HLA-B*5101 was increased in both types of MS patients compared with controls. The frequency of HLA-DRB1*1501 was increased in Western type MS and the frequency of HLA-DRB1*0802 was increased in Asian type MS compared to controls. After correction of P values, the association of Western type MS patients with HLA-DRB1*1501 was statistically significant (Pc=0.0003) whereas other HLA alleles showed no significant association. These results suggest that HLA class I (HLA-A and -B) alleles may not contribute to a strong susceptibility to MS in Japanese compared to HLA class II (HLA-DRB1) alleles.

UI MeSH Term Description Entries
D007564 Japan A country in eastern Asia, island chain between the North Pacific Ocean and the Sea of Japan, east of the Korean Peninsula. The capital is Tokyo. Bonin Islands
D009103 Multiple Sclerosis An autoimmune disorder mainly affecting young adults and characterized by destruction of myelin in the central nervous system. Pathologic findings include multiple sharply demarcated areas of demyelination throughout the white matter of the central nervous system. Clinical manifestations include visual loss, extra-ocular movement disorders, paresthesias, loss of sensation, weakness, dysarthria, spasticity, ataxia, and bladder dysfunction. The usual pattern is one of recurrent attacks followed by partial recovery (see MULTIPLE SCLEROSIS, RELAPSING-REMITTING), but acute fulminating and chronic progressive forms (see MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE) also occur. (Adams et al., Principles of Neurology, 6th ed, p903) MS (Multiple Sclerosis),Multiple Sclerosis, Acute Fulminating,Sclerosis, Disseminated,Disseminated Sclerosis,Sclerosis, Multiple
D006684 HLA-DR Antigens A subclass of HLA-D antigens that consist of alpha and beta chains. The inheritance of HLA-DR antigens differs from that of the HLA-DQ ANTIGENS and HLA-DP ANTIGENS. HLA-DR,Antigens, HLA-DR,HLA DR Antigens
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000483 Alleles Variant forms of the same gene, occupying the same locus on homologous CHROMOSOMES, and governing the variants in production of the same gene product. Allelomorphs,Allele,Allelomorph
D015234 HLA-A Antigens Polymorphic class I human histocompatibility (HLA) surface antigens present on almost all nucleated cells. At least 20 antigens have been identified which are encoded by the A locus of multiple alleles on chromosome 6. They serve as targets for T-cell cytolytic responses and are involved with acceptance or rejection of tissue/organ grafts. Antigens, HLA-A,HLA-A,Antigens, HLA A,HLA A Antigens
D015235 HLA-B Antigens Class I human histocompatibility (HLA) surface antigens encoded by more than 30 detectable alleles on locus B of the HLA complex, the most polymorphic of all the HLA specificities. Several of these antigens (e.g., HLA-B27, -B7, -B8) are strongly associated with predisposition to rheumatoid and other autoimmune disorders. Like other class I HLA determinants, they are involved in the cellular immune reactivity of cytolytic T lymphocytes. Antigens, HLA-B,HLA-B Antigen,HLA-B,Antigen, HLA-B,Antigens, HLA B,HLA B Antigen,HLA B Antigens
D059811 HLA-DRB1 Chains A subtype of HLA-DRB beta chains that includes over one hundred allele variants. The HLA-DRB1 subtype is associated with several of the HLA-DR SEROLOGICAL SUBTYPES. HLA DRB1,HLA-DRB1,HLA-DRB1 Antigen,Antigen, HLA-DRB1,Chains, HLA-DRB1,HLA DRB1 Antigen,HLA DRB1 Chains

Related Publications

T Ono, and M R Zambenedetti, and K Yamasaki, and Y Kawano, and N Kamikawaji, and H Ito, and M Sakurai, and Y Nishimura, and J Kira, and I Kanazawa, and T Sasazuki
April 1995, European journal of immunogenetics : official journal of the British Society for Histocompatibility and Immunogenetics,
T Ono, and M R Zambenedetti, and K Yamasaki, and Y Kawano, and N Kamikawaji, and H Ito, and M Sakurai, and Y Nishimura, and J Kira, and I Kanazawa, and T Sasazuki
April 1991, Tissue antigens,
T Ono, and M R Zambenedetti, and K Yamasaki, and Y Kawano, and N Kamikawaji, and H Ito, and M Sakurai, and Y Nishimura, and J Kira, and I Kanazawa, and T Sasazuki
December 2000, The Journal of rheumatology,
T Ono, and M R Zambenedetti, and K Yamasaki, and Y Kawano, and N Kamikawaji, and H Ito, and M Sakurai, and Y Nishimura, and J Kira, and I Kanazawa, and T Sasazuki
March 1998, Tissue antigens,
T Ono, and M R Zambenedetti, and K Yamasaki, and Y Kawano, and N Kamikawaji, and H Ito, and M Sakurai, and Y Nishimura, and J Kira, and I Kanazawa, and T Sasazuki
February 2000, Tissue antigens,
T Ono, and M R Zambenedetti, and K Yamasaki, and Y Kawano, and N Kamikawaji, and H Ito, and M Sakurai, and Y Nishimura, and J Kira, and I Kanazawa, and T Sasazuki
November 2021, Experimental dermatology,
T Ono, and M R Zambenedetti, and K Yamasaki, and Y Kawano, and N Kamikawaji, and H Ito, and M Sakurai, and Y Nishimura, and J Kira, and I Kanazawa, and T Sasazuki
September 2010, Journal of neuroimmunology,
T Ono, and M R Zambenedetti, and K Yamasaki, and Y Kawano, and N Kamikawaji, and H Ito, and M Sakurai, and Y Nishimura, and J Kira, and I Kanazawa, and T Sasazuki
December 1995, Annals of the rheumatic diseases,
T Ono, and M R Zambenedetti, and K Yamasaki, and Y Kawano, and N Kamikawaji, and H Ito, and M Sakurai, and Y Nishimura, and J Kira, and I Kanazawa, and T Sasazuki
March 1997, Neurology,
T Ono, and M R Zambenedetti, and K Yamasaki, and Y Kawano, and N Kamikawaji, and H Ito, and M Sakurai, and Y Nishimura, and J Kira, and I Kanazawa, and T Sasazuki
September 1997, Tissue antigens,
Copied contents to your clipboard!